Form 4: Inari Medical Director William Hoffman Sells Shares Under 10b5-1 Trading Plan
SEC Form 4
Director William Hoffman sold 1,451 shares of Inari Medical (NARI) at $40 per share on April 16, 2024, under a pre-arranged Rule 10b5-1 trading plan.
Summary
- William Hoffman, a director at Inari Medical, Inc. (NARI), sold 1,451 shares of common stock on April 16, 2024.
- The sale was executed at a price of $40 per share.
- Following the transaction, Hoffman still beneficially owns 999,782 shares of Inari Medical.
- The transaction was conducted under a Rule 10b5-1 trading plan adopted on December 14, 2023.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the transaction is a routine sale under a pre-arranged trading plan and doesn't necessarily indicate a positive or negative outlook on the company.
Industry Context
Sales by insiders are a common occurrence and are often related to personal financial planning. The use of a 10b5-1 trading plan allows insiders to sell shares at predetermined times and prices, avoiding accusations of insider trading.
Stakeholder Impact
- The sale of shares by a director could be perceived negatively by some shareholders, but the existence of a 10b5-1 trading plan mitigates this concern.
Key Dates
| Date | Description |
|---|---|
| December 14, 2023 | Date of adoption of Rule 10b5-1 trading plan |
| April 16, 2024 | Date of transaction (sale of shares) |
| April 18, 2024 | Date of Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.